Loading...
Immunotherapies & Innovations for Infectious Diseases Congress 2021

November 15 & 16 LYON, France

News Twitter

Program

Day 1

Monday, 15th November 2021

8h00

Registration & welcome coffee

8h45

Welcome Address

9h00

Keynote lectures

UNAIDS Michel Kazatchkine

Michel Kazatchkine
Special Advisor
Joint United Nations Program on AIDS (UNAIDS)
Affiliate / course director
Global Health Center, the Graduate Institute of International and Development Studies, Geneva

Boerhinger Ingelheim, France Egbert Mundt

Egbert Mundt
Head New Biological Entities
Boerhinger Ingelheim, France

10h00

Coffee Break - Exhibition Hall - B2B Meetings

10h30

Track 1 : Anti-infectious approaches

Session 1

Aix Marseille Université, France Xavier de Lamballerie

Xavier de Lamballerie
Professor
Aix Marseille Université, France

Trained immunity: a memory for innate host defense
Radboud University Medical Center Xavier de Lamballerie

Mihai Netea
Professor & Head of the division of Experimental Medicine
Department of Internal Medicine, Radboud University Medical Center, The Netherlands

CD40 agonists boost IFN-induced signaling pathway and subsequent anti-HBV response in vitro and in vivo
Evotec Antoine Alam

Antoine Alam
Antiviral Reaserch Head
Evotec, France

Track 2 : Prediction of future outbreaks

Pasteur Institute Sylvie van Der Werf

Sylvie van Der Werf
Head of Molecular Genetics of RNA viruses
Pasteur Institute, France

Ausvet Angus Cameron

Angus Cameron
Executive Consultant
Ausvet, France

Presentation of Infectiotron project
INRAE Fabienne Archer

Fabienne Archer
Research director
INRAE
Director
Viral Infections and Comparative Pathology laboratory IVPC, Lyon1, INRAE, EPHE, France

CNRS Fabrice Vavre

Fabrice Vavre
Research director
CNRS
Director
Laboratory of Biometry and Evolutionary Biology, Lyon 1, CNRS, VetAgro Sup, France

12h00

Lunch - Poster Presentation - B2B Meetings 5 slots - Exhibition Hall

14h00

Track 1 : Anti-infectious approaches

Session 2

Hôpital Bicêtre AP-HP Thierry Naas

Thierry Naas
Co-director
CNR antibiorésistance, Hôpital Bicêtre AP-HP, France

Phage therapy, an alternative approach to antibiotics ?
Bioaster Gilles Courtemanche

Gilles Courtemanche
Antimicrobials Program Head
Bioaster

BioVersys Michel Pieren

Michel Pieren
Clinical Project Manager
BioVersys, Switzerland

Track 3 : New tools for monitoring diagnosis and pronostics

IARC BIOBANK Zisis Kozlakidis

Zisis Kozlakidis
Director
IARC BIOBANK, France

Current trends in microbiological diagnostics
bioMérieux Alex van Belkum

Alex van Belkum
Scientific Director of Microbiology
bioMérieux, France

16h00

Coffee Break - Exhibition Hall - B2B Meetings

16h30

Track 1 : Anti-infectious approaches

Session 3

Enlivex Oren Hershkovitz

Oren Hershkovitz
CEO
Enlivex, Israel

A novel therapeutic approach for the treatment of shiga-toxin producing E. coli infections.
Eligo Bioscience Edith Hessel

Edith Hessel
Chief Scientific Officer
Eligo Bioscience, France

Enterome Christophe Bonny

Christophe Bonny
Chief Scientific Officer
Enterome, France

Pitch Session

18h00

End of Day 1

20h00

Cocktail Dinner

Day 2

Tuesday, 16th November 2021

8h30

Welcome coffee

9h00

Keynote lectures

GARDP Jean-Pierre Paccaud

Jean-Pierre Paccaud
Director of Business Development and Corporate Strategy
GARDP, Switzerland

10h00

Coffee Break - Exhibition Hall - B2B Meetings

10h30

Track 4 : Next-generation vaccines

Session 1

Institut Karolinska Karin Loré

Karin Loré
Professor
Institut Karolinska, Sweden

BioNTech Alexander Muik

Alexander Muik
Director Immunomodulators
BioNTech, Germany

Sanofi Pasteur Paul Desert

Paul Desert
Head of Non-Clinical Safety
Sanofi Pasteur, France

Sanofi Pasteur Joël Le-Pape

Joël Le-Pape
Data Scientist
Sanofi Pasteur, France

Track 5 : Leveraging clinical trials data

Session 1

Faculty of medicine of Geneva Arnaud Didierlaurent

Arnaud Didierlaurent
Professor
Faculty of medicine of Geneva, Switzerland

Optimizing clinical trials in an emerging infectious disease crisis
Pasteur Institute Bruno Hoen

Bruno Hoen
Professor, Medical Research Director
Pasteur Institute, France

12h00

Lunch - Poster Presentation - B2B Meetings 5 slots - Exhibition Hall

14h00

Track 4 : Next-generation vaccines

Session 2

Ghent University Bert Devriendt

Bert Devriendt
Assistant Professor
Ghent University, Belgium

Janssen Vaccines Jenny Hendricks

Jenny Hendricks
Head Biomarkers Viral Vaccines
Janssen Vaccines, The Netherlands

RNA Synthesis – Tools and tips to Take You From Template to Transcript and from R&D to scale up
New England Biolab Morgane Moreau

Morgane Moreau
Technical Sales Engineer
New England Biolab

Track 5 : Leveraging clinical trials data

Session 1

Inotrem Margarita Salcedo-Magguilli

Margarita Salcedo-Magguilli
Chief Development Officer
Inotrem, France

University of Edinburgh Kenneth Baillie

Kenneth Baillie
Snr. Clinical Research Fellow in Anaesthesia & Critical Care
University of Edinburgh, Scotland

16h00

Closing keynote

INSERM Marie-Paul Kieny

Marie-Paul Kieny
Research director
INSERM, France

16h30

Best Poster - Annoucemment of next year edition

16h45

End of congress

ORGANIZERS